• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CENTURION VISION SYSTEM, ACCESSORY, ACTIVE SENTRY HANDPIECE; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CENTURION VISION SYSTEM, ACCESSORY, ACTIVE SENTRY HANDPIECE; UNIT, PHACOFRAGMENTATION Back to Search Results
Catalog Number 8065752914
Device Problem Energy Output Problem (1431)
Patient Problems Vitreous Loss (2142); Capsular Bag Tear (2639); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 04/28/2021
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A surgeon reported that during a cataract extraction with intraocular lens (iol) implant procedure the phacoemulsification (phaco) tip was blocked and the phaco handpiece ultrasonic power was less than normal.The tip was immersed into a cup of solution and applying 100% ultrasonic power attempted to clear the tip.Phaco power modulation continued even with the numbers showing as rising on the system.The tip and handpiece was exchanged but the blockage continued.The patient exhibited progressive zonular dehiscence.Multiple attempts to emulsify the nucleus failed.The surgeon switched to extracapsular cataract extraction procedure.The wound was enlarged and the capsulorhexis was performed.The mostly intact nucleus was removed with a loop instrument.This resulted in vitreous prolapse and an anterior vitrectomy was required.The capsular bag was removed and anterior iol was inserted.The patient was prescribed antibiotic and steroid drops.
 
Manufacturer Narrative
Additional information has been provided.The phaco handpiece was not returned for evaluation.The phaco handpiece manufacturing device history record (dhr) was reviewed.Based on qa assessment, the product met specifications at the time of release.With no additional, related information provided and no sample received for evaluation at this time, the customer reported event could not be confirmed.The root cause cannot be determined conclusively.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTURION VISION SYSTEM, ACCESSORY, ACTIVE SENTRY HANDPIECE
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
MDR Report Key11893325
MDR Text Key252906629
Report Number2028159-2021-00542
Device Sequence Number1
Product Code HQC
UDI-Device Identifier00380657529148
UDI-Public00380657529148
Combination Product (y/n)N
PMA/PMN Number
K161794
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number8065752914
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/03/2021
Initial Date FDA Received05/27/2021
Supplement Dates Manufacturer Received08/05/2021
Supplement Dates FDA Received08/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CENTURION SURGICAL PROCEDURE PAK.; CENTURION VISION SYSTEM WITH ACTIVE SENTRY.; CENTURION SURGICAL PROCEDURE PAK; CENTURION VISION SYSTEM WITH ACTIVE SENTRY
Patient Outcome(s) Required Intervention;
-
-